Three new drugs mark a new era for rheumatoid arthiritis treatment, according to work by an international research team including Professor Paul Emery from the University of Leeds. Their findings are published in the Lancet today (June 13).
The Food and Drug Administration expanded its marketing approval for Remicade on Monday. Remicade is a psoriatic arthritis treatment produced by Centocor that first received FDA approval in May of last year.
Inflammatory diseases drug developed - Breaking News - National - Breaking News
"Australian scientists say they have developed a drug that may help prevent and reverse debilitating inflammatory diseases, including rheumatoid arthritis."